Mesenteric Infiltration in Ovarian Cancer
Conditions: Ovary Cancer Interventions: Diagnostic Test: Computed Tomography Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Danube University Krems; Institut du Cancer de Montpellier - Val d ' Aurelle; Ente Ospedaliero Cantonale, Ticino, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Erdafitinib in Metastatic Steroid-cell Ovarian Cancer
Conditions: Ovarian Cancer; Steroid Cell Tumor, Malignant Interventions: Drug: Erdafitinib Sponsors: University Health Network, Toronto Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours
Conditions: Germ Cell Ovarian Cancer; Germ Cell Tumor; Germ Cell Cancer; Germ Cell Neoplasia; Ovary Cancer; Ovary Neoplasm; Ovarian Cancer; Ovarian Neoplasms Interventions: Diagnostic Test: Blood test; Diagnostic Test: Pathology specimen miRNA expression Sponsors: Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
Conditions: Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Spatial Radiogenomics of Ovarian Cancer: Implementation of a Lesion-specific 3D-printed Mould Pipeline in the Clinical Workflow for Image-guided Tissue Multi-sampling of Ovarian Tumours
Conditions: Ovarian Cancer Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Conditions: Platinum-resistant Ovarian Cancer; Recurrent Ovary Cancer; Ovarian Cancer; Ovarian Carcinoma; Ovarian Carcinoma, Recurrent Interventions: Biological: Cytokine-Induced Memory-like Natural Killer Cells; Biological: IL-15 Superagonist Sponsors: Dana-Farber Cancer Institute; ImmunityBio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression
Conditions: Ovarian Cancer Sponsors: Ain Shams University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids
Conditions: Ovarian Cancer Interventions: Other: growth prediction of ovarian cancer organoids in the frame of bright field image by leveraging AI Sponsors: Chongqing University Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
Conditions: Platinum-resistant Ovarian Cancer; Refractory Ovarian Carcinoma Interventions: Drug: CBX-12 Sponsors: Cybrexa Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer
Conditions: Epithelial Ovarian Cancer; Stage III Ovarian Cancer; Stage IV Ovarian Cancer Sponsors: The First Hospital of Jilin University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Conditions: Surgery Interventions: Behavioral: Educational Module; Procedure: Salpingectomy Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
Conditions: Recurrent Ovarian Cancer Interventions: Drug: Bevacizumab ； HRS-1167 Sponsors: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
Conditions: Cancer; Solid Tumor; Colorectal Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Targeted Therapy; Chemotherapy; Immunotherapy; Precision Therapy Interventions: Genetic: SNP; Drug: Palbociclib 125mg; Drug: Bevacizumab Sponsors: Lebanese University; Haykel Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
Conditions: Ovarian Cancer Interventions: Behavioral: Assess the response to platinum-based chemotherapy in correlation to BRCA status in neoadjuvant and recurrent ovarian cancer Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Conditions: Ovary Neoplasm; Ovarian Cancer; Epithelial Ovarian Cancer; Recurrent Interventions: Biological: iC9-CAR.B7-H3 T cells; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: UNC Lineberger Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
